Prevention of hepatitis B virus reactivation under rituximab therapy

Immunotherapy
Yutaka TsutsumiNobuo Masauzi

Abstract

Rituximab is a useful drug for the treatment of B-cell non-Hodgkin's lymphoma, and its use has been extended to other diseases such as idiopathic thrombocytopenic purpura and chronic rheumatoid arthritis. One serious complication associated with rituximab use is reactivation of hepatitis B virus, and the search for methods to prevent this occurrence has resulted in a rapid accumulation of knowledge in recent years. In this review, we will discuss case studies from our group, as well as other groups, and outline current knowledge on the topic together with issues that remain to be resolved.

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L T SohY W Ong
Sep 1, 1990·Hematological Oncology·R H LiangE K Chiu
Sep 1, 1987·American Journal of Epidemiology·A S LokH J Lin
Jul 1, 1985·Archives of Internal Medicine·S N ThungH Gilbert
Apr 1, 1982·Annals of Internal Medicine·J H HoofnagleJ Costa
Oct 23, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D G MaloneyR Levy
Jul 8, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K TobinaiT Murate
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S CzuczmanC Varns
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A DavisR Levy
Feb 26, 2000·British Journal of Haematology·F SilvestriM Baccarani
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G J WebsterA Bertoletti
Feb 24, 2001·The New England Journal of Medicine·L KrishnamurtiJ E Wagner
May 25, 2001·International Journal of Hematology·T IgarashiUNKNOWN IDEC-C2B8 Study Group
May 29, 2001·Gastroenterology·A S LokJ H Hoofnagle
Sep 29, 2001·The New England Journal of Medicine·C Landrigan
Dec 4, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S LokUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Jan 5, 2002·American Journal of Hematology·T HamakiY Mutou
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Jun 26, 2002·Journal of Viral Hepatitis·Ke-Qin Hu
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T IgarashiUNKNOWN IDEC-C2B8 Study Group in Japan
May 17, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·Masahiro KamiYoshitomo Mutou
Jun 18, 2003·Journal of Clinical Gastroenterology·Nicole D SimpsonAijaz Ahmed
Feb 26, 2004·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·Jean-Pierre Allain
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F LokUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD)

❮ Previous
Next ❯

Citations

Aug 31, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jessica P HwangRohit Loomba
Mar 16, 2012·International Journal of Hematology·Yutaka TsutsumiMasahiro Imamura
Dec 29, 2010·Hepatitis Research and Treatment·Yutaka TsutsumiMasahiro Imamura
Nov 12, 2013·BMC Cancer·Jessica P HwangMaria E Suarez-Almazor
Jul 13, 2011·Advances in Hematology·Yutaka TsutsumiMasahiro Imamura
Jan 29, 2011·Expert Opinion on Biological Therapy·Matthew B Carroll
Sep 6, 2011·La Revue de médecine interne·B TerrierUNKNOWN Groupe d'étude et de recherche en médecine interne et maladies infectieuses sur le virus de l’hépatite C (GERMIVIC)
Sep 29, 2015·World Journal of Hepatology·Yutaka TsutsumiTakanori Teshima
Oct 2, 2015·Proceedings·Jonathan RamirezDawn M Sears

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.